AlphAIAlphAI — Financial news for AI agents
tradingview.comOCT 271 min read$UHS

Universal Health Services, Inc. (UHS) Q3 Rev +5.3% to $4.73B; EPS $5.22, Down YoY

Universal Health Services, Inc. (UHS) reported Q3 2026 revenue of $4.733B, up 5.3% YoY, and EPS of $5.22, down from $5.86 in Q3 2025. Adjusted EBITDA net of NCI was $624.6M, down from $670.6M. The company noted steady revenue growth but softer margins.

Original reporting
tradingview.com
Published Oct 27, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 27, 2026, 8:28 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Universal Health Services, Inc. (UHS) Q3 Rev +5.3% to $4.73B; EPS $5.22, Down YoY — source image
Source · tradingview.com
Decision brief

The 30-second read

$UHSBearishMed
01

Why it matters

The earnings miss on EPS may trigger a sell-off, while revenue growth offers a modest upside narrative.

02

Market read

UHS earnings provide fresh data for healthcare sector investors and may affect related stocks.

03

What to watch

Potential insurance recoveries and liability settlements could improve future margins if realized.

Relevance 8/10Novelty 8/10Timing: post-market

Background

Universal Health Services released its Q3 2026 earnings, showing modest revenue growth but weaker profitability.

Company-level read

Ticker impact

$UHSBearishHigh confidence
Context

UHS reported Q3 2026 revenue of $4.733B (+5.3% YoY) and EPS $5.22, marking the first public disclosure of its quarterly results.

Expected impact

likely downside as investors price in softer margins and lower EPS versus prior year.

Evidence & confidence

The earnings release is fresh information; EPS miss and margin decline are typical bearish catalysts.

Market effects

Sector

UHS results may influence the broader healthcare services sector, highlighting margin pressure trends.

Regional

UHS is a U.S. healthcare provider; impact is primarily on U.S. markets.

Global

Limited global relevance beyond U.S. healthcare investors.

Counterpoint

What could challenge this read

Despite EPS miss, revenue growth could support a short-term rally if investors focus on top-line strength.

Key entities

  • company
    Universal Health Services, Inc.

    U.S.-based provider of acute care and behavioral health services.

Read at source← All news

StoryUniversal Health Services posts Q3 2026 revenue up 5.3% to $4.73 B, EPS $5.22 and completes Talkspace acquisition

Also covered by

4 outlets

Related articles

OCT 27
$UHSHigh

Universal Health Services falls 3% on legal settlement concerns

Universal Health Services (UHS) reported Q3 earnings of $5.22 per share, beating estimates by $0.02, with revenue up 5.3% YoY to $4.73B. Shares fell 3% after-hours due to legal settlement costs and Medicaid payment uncertainties. The quarter included a $26M charge for a tentative settlement in Cumberland Hospital litigation, partially offset by a $21M Medicaid payment benefit. UHS repurchased 1.35M shares at $242.1M.

investing.com2 min
OCT 27
$UHSHigh

UNIVERSAL HEALTH SERVICES INC (UHS): ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2026

UNIVERSAL HEALTH SERVICES INC (UHS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE October 27, 2026 CONTACT: Darren Lehrich Vice President-Investor Relations 610-382-3310 Darren.Lehrich@uhsinc.com UNIVERSAL HEALTH SERVICES, INC. ANNOUNCES FINANCIAL RESULTS FOR THE THREE AND NINE-MONTH PERIODS ENDED SEPTEMBER 30, 2026 Consolida

SEC EDGAR 8-K2 min
OCT 27
$UHSHighAI 8/10

Universal Health Services (NYSE:UHS) posts Q3 2026 sales in line with estimates

Universal Health Services (UHS) reported Q3 2026 revenue of $4.73 billion, matching estimates and showing 5.3% year-on-year growth. Adjusted EPS beat estimates at $5.22, while adjusted EBITDA missed at $624.6 million. Operating margin declined to 9.6% from 11.6% year-on-year, but free cash flow margin improved to 8.9% from 3.4%. Same-store sales rose 4.7% year-on-year, up from 2% in the prior year quarter.

finance.yahoo.com1 min